Lifesplice Pharma LLC Profile last edited on: 11/4/2019
CAGE: 66KY6
UEI: ZWZRCWKUDYH8
Business Identifier: Treatment of severe neurological and non-neurological diseases 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
1 Great Valley Parkway Suite 20
Malvern, PA 19355
Malvern, PA 19355
| (610) 296-5401 |
| info@lifesplicepharma.com |
| www.lifesplicepharma.com |
Location: Single
Congr. District: 06
County: Chester
Congr. District: 06
County: Chester
Public Profile
LifeSplice is a biotechnology company developing products for the treatment of severe neurological and non-neurological diseases with critical unmet needs. The firm's proprietary drug discovery technology offers partners a valuable mechanism rapidly to identify and initiate preclinical product development across a broad range of therapeutic areas including cancer, infectious diseases, and rare genetic disorders.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2019 | 2 | NIH | $673,233 | |
| Project Title: Preclinical Evaluation of an Scn8a-Directed Splice Modulating Oligonucleotide to Treat Dravet Syndrome | ||||
| 2019 | 2 | NIH | $575,481 | |
| Project Title: Preclinical Testing of Splice Modulating Oligonucleotides Targeting Scn8a to Treat Dravet Syndrome | ||||
| 2016 | 2 | NIH | $3,215,294 | |
| Project Title: Oligonucleotides That Modulate Ampa Receptor Alternative Splicing as Drug Candida | ||||
| 2012 | 2 | NIH | $494,735 | |
| Project Title: Characterizing an Ampa Receptor Splice Modulator in Preventing Epileptogenesis | ||||
Key People / Management
Gordon J Lutz -- Co-Founder and CEO
Michael A Christini -- Vp Business Development
Nicole M Lykens
Melanie K Tallent -- Co-Founder and CSO
Michael A Christini -- Vp Business Development
Nicole M Lykens
Melanie K Tallent -- Co-Founder and CSO
Company News
There are no news available.
